PB 12 of 2019

National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 2)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 26 February 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1               Name of Instrument

(1)           This Instrument is the National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 2).

(2)           This Instrument may also be cited as PB 12 of 2019.

2               Commencement

This Instrument commences on 1 March 2019.

3               Amendment of National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1  Amendments

[1]           Schedule 1, after entry for Bicalutamide in the form Tablet 50 mg

insert:

[2]           Schedule 1, after entry for Insulin lispro in the form Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

insert:

[3]           Schedule 1, after entry for Ivabradine in the form Tablet 7.5 mg (as hydrochloride)

insert:

[4]           Schedule 1, after entry for Risedronic acid and calcium in the form Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate)

insert:

[5]           Schedule 1, after entry for Varenicline in the form Tablet 1 mg (as tartrate)

insert: